LASA logo

LASA Supergenerics LTD

LASA·NSE·
6.76 -0.16 (-2.31%)
Market Cap34.37 Cr
PE Ratio-2.10
Volume23,473
Day High - Low7.04 - 6.75
52W High-Low14.08 - 5.67
DocStoX Score
0.0/10
Poor
Fair Value
Sign in to see
ROE
-68.00%
Weak
P/E
-2.10x
Loss-making
Debt / Equity
0.20
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor

Price performance

Day6.75
7.04
52W5.67
14.08
DocStoX take

Supported by valuation (6.0), but held back by momentum (0.0).

DocStoX score

Low confidence
0.0
/10
Poor
Quality
Weak
ROE -68.0%
Valuation
Fair
P/B 0.7× on assets (no earnings to value)
Growth
Flat
Revenue -34.0% 5Y CAGR
Risk
Elevated
D/E 0.20
Momentum
Weak
13% of 52-week range

At a glance

Market Cap
₹34 Cr
52W High / Low
₹14 / ₹6
Dividend Yield
3.59%
Promoter Holding
53.65%
EPS (TTM)
₹-6.80
Book Value
₹10.00

Key highlights

  • Low leverage — D/E 0.20
  • Loss-making — no meaningful P/E
  • Revenue shrinking 34% a year
1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

LASA SUPERGENERICS LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.